Krystal Biotech (KRYS)

Krystal Biotech (KRYS) Stock Price & Analysis


KRYS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$49.17 - $124.23
Previous Close$124.2
Average Volume (3M)271.51K
Market Cap
Enterprise Value$2.86B
Total Cash (Recent Filing)$350.39M
Total Debt (Recent Filing)$8.76M
Price to Earnings (P/E)-23.5
Aug 07, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.28
Shares Outstanding25,799,738
10 Day Avg. Volume614,902
30 Day Avg. Volume271,515
Standard Deviation0.17
Financial Highlights & Ratios
Price to Book (P/B)6.21
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-29.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-27.49
Price Target Upside15.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Krystal Biotech’s price range in the past 12 months?
Krystal Biotech lowest stock price was $49.17 and its highest was $124.23 in the past 12 months.
    What is Krystal Biotech’s market cap?
    Currently, no data Available
    When is Krystal Biotech’s upcoming earnings report date?
    Krystal Biotech’s upcoming earnings report date is Aug 07, 2023 which is in 62 days.
      How were Krystal Biotech’s earnings last quarter?
      Krystal Biotech released its earnings results on May 08, 2023. The company reported -$1.76 earnings per share for the quarter, missing the consensus estimate of -$1.438 by -$0.322.
        Is Krystal Biotech overvalued?
        According to Wall Street analysts Krystal Biotech’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Krystal Biotech pay dividends?
          Krystal Biotech does not currently pay dividends.
          What is Krystal Biotech’s EPS estimate?
          Krystal Biotech’s EPS estimate is -$1.31.
            How many shares outstanding does Krystal Biotech have?
            Krystal Biotech has 25,799,738 shares outstanding.
              What happened to Krystal Biotech’s price movement after its last earnings report?
              Krystal Biotech reported an EPS of -$1.76 in its last earnings report, missing expectations of -$1.438. Following the earnings report the stock price went up 4.048%.
                Which hedge fund is a major shareholder of Krystal Biotech?
                Among the largest hedge funds holding Krystal Biotech’s share is Deerfield Management Company, LP. It holds Krystal Biotech’s shares valued at 25M.


                  Krystal Biotech Stock Smart Score

                  The Krystal Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Krystal Biotech

                  Krystal Biotech, Inc. is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases for which company believe there are no known effective treatments. The company was founded by Suma M. Krishnan in December 2017 and is headquartered in Pittsburgh, PA.


                  Top 5 ETFs holding KRYS

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  iShares Biotechnology ETF
                  Vanguard Health Care ETF
                  Invesco DWA Healthcare Momentum ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold KRYS. The ETFs are listed according to market value of KRYS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Accelerate Diagnostics
                  Bellicum Pharmaceuticals
                  Crispr Therapeutics AG
                  Editas Medicine

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis